The ACS National Spring Meeting took place 7-11 April in New Orleans.

As is traditional for the Medicinal Chemistry Division, structures of candidate drugs get revealed in the “First-Time Disclosures” session.

This year’s entries are:

• – BMS-906024, Notch Signaling Inhibitor

• – LGX818, Made To Fight Melanoma

• – AZD5423, For Chronic Obstructive Pulmonary Disease

• – Birinapant, Apoptosis Inhibitor

• – MGL-3196, Thyroid Hormone Analog

More about how where these drugs discovered:http://cen.acs.org/articles/91/i16/Five-New-Drug-Candidates-Structures.html